ArticleFrontiers in immunology2021

Improvement of PD-1 Blockade Efficacy and Elimination of Immune-Related Gastrointestinal Adverse Effect by mTOR Inhibitor.

Xin Bai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.